EP3454893A4 - Zusammensetzung mit antigenen und einem schleimhautadjuvans und verfahren zur verwendung - Google Patents

Zusammensetzung mit antigenen und einem schleimhautadjuvans und verfahren zur verwendung Download PDF

Info

Publication number
EP3454893A4
EP3454893A4 EP16901833.0A EP16901833A EP3454893A4 EP 3454893 A4 EP3454893 A4 EP 3454893A4 EP 16901833 A EP16901833 A EP 16901833A EP 3454893 A4 EP3454893 A4 EP 3454893A4
Authority
EP
European Patent Office
Prior art keywords
mucosus
antigens
adjuvant
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16901833.0A
Other languages
English (en)
French (fr)
Other versions
EP3454893A1 (de
Inventor
Grant WEAVER
Jeff KULA
Boh Chang LIN
Karen Brown
Wesley W. JOHNSON
Michael Dennis MURPHY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phibro Animal Health Corp
Original Assignee
Phibro Animal Health Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phibro Animal Health Corp filed Critical Phibro Animal Health Corp
Publication of EP3454893A1 publication Critical patent/EP3454893A1/de
Publication of EP3454893A4 publication Critical patent/EP3454893A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP16901833.0A 2016-05-11 2016-05-11 Zusammensetzung mit antigenen und einem schleimhautadjuvans und verfahren zur verwendung Withdrawn EP3454893A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/031902 WO2017196318A1 (en) 2016-05-11 2016-05-11 A composition comprising antigens and a mucosal adjuvant and a method for using

Publications (2)

Publication Number Publication Date
EP3454893A1 EP3454893A1 (de) 2019-03-20
EP3454893A4 true EP3454893A4 (de) 2020-01-01

Family

ID=60267492

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16901833.0A Withdrawn EP3454893A4 (de) 2016-05-11 2016-05-11 Zusammensetzung mit antigenen und einem schleimhautadjuvans und verfahren zur verwendung

Country Status (3)

Country Link
EP (1) EP3454893A4 (de)
CA (1) CA3022006A1 (de)
WO (1) WO2017196318A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112457397A (zh) * 2020-11-26 2021-03-09 西北农林科技大学 一种prrsv n蛋白的纳米抗体及其制备方法和应用

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944942A (en) * 1987-08-27 1990-07-31 Mobay Corporation Intranasal vaccination of horses with inactivated microorganisms or antigenic material
EP1001025A2 (de) * 1998-10-22 2000-05-17 Pfizer Products Inc. Hauptproteine der Aussenmembran von actinobacillus pleuropneumoniae
WO2002049666A2 (en) * 2000-12-19 2002-06-27 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
US20110123570A1 (en) * 2009-11-10 2011-05-26 Boehringer Ingelheim Vetmedica, Inc. Actinobacillus suis antigens
WO2014004361A1 (en) * 2012-06-27 2014-01-03 Merial Limited Attenuated streptococcus suis vaccines and methods of making and use thereof
CN104511015A (zh) * 2013-09-30 2015-04-15 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法与应用
CN110075289A (zh) * 2019-04-19 2019-08-02 河南省农业科学院畜牧兽医研究所 一种副猪嗜血杆菌、猪链球菌与胸膜肺炎放线杆菌三联灭活疫苗及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005230708B2 (en) * 2004-04-05 2009-01-15 Zoetis Services Llc Microfluidized oil-in-water emulsions and vaccine compositions
US7829274B2 (en) * 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
CA2722765C (en) * 2008-04-28 2016-10-04 Novartis Ag Nanoparticles for use in pharmaceutical compositions
HRP20151031T1 (hr) * 2011-02-17 2015-11-06 Boehringer Ingelheim Vetmedica Gmbh Novi europski soj prrsv
EP2699689A4 (de) * 2011-04-21 2014-12-17 Univ Utrecht Holding Bv Streptococcus-bakteriophagen-lysine zur behandlung von gram-positiven bakterien in haustieren und nutztieren

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944942A (en) * 1987-08-27 1990-07-31 Mobay Corporation Intranasal vaccination of horses with inactivated microorganisms or antigenic material
EP1001025A2 (de) * 1998-10-22 2000-05-17 Pfizer Products Inc. Hauptproteine der Aussenmembran von actinobacillus pleuropneumoniae
WO2002049666A2 (en) * 2000-12-19 2002-06-27 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
US20110123570A1 (en) * 2009-11-10 2011-05-26 Boehringer Ingelheim Vetmedica, Inc. Actinobacillus suis antigens
WO2014004361A1 (en) * 2012-06-27 2014-01-03 Merial Limited Attenuated streptococcus suis vaccines and methods of making and use thereof
CN104511015A (zh) * 2013-09-30 2015-04-15 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法与应用
CN110075289A (zh) * 2019-04-19 2019-08-02 河南省农业科学院畜牧兽医研究所 一种副猪嗜血杆菌、猪链球菌与胸膜肺炎放线杆菌三联灭活疫苗及其应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MAYANK CHATURVEDI ET AL: "A review on mucoadhesive polymer used in nasal drug delivery system", JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH, vol. 2, no. 4, 1 October 2011 (2011-10-01), pages 215 - 222, XP055232682, DOI: 10.4103/2231-4040.90876 *
See also references of WO2017196318A1 *
SHARAD MANGAL ET AL: "Evaluation of mucoadhesive carrier adjuvant: Toward an oral anthrax vaccine", ARTIFICIAL CELLS, NANOMEDICINE AND BIOTECHNOLOGY, vol. 42, no. 1, 1 February 2014 (2014-02-01), US, pages 47 - 57, XP055645252, ISSN: 2169-1401, DOI: 10.3109/21691401.2013.769447 *
WANG SHUJING ET AL: "Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies", PROTEIN & CELL, SPRINGER ASIA, BEIJING, CN, vol. 6, no. 7, 6 May 2015 (2015-05-06), pages 480 - 503, XP035507308, ISSN: 1674-800X, [retrieved on 20150506], DOI: 10.1007/S13238-015-0164-2 *

Also Published As

Publication number Publication date
EP3454893A1 (de) 2019-03-20
CA3022006A1 (en) 2017-11-16
WO2017196318A1 (en) 2017-11-16

Similar Documents

Publication Publication Date Title
FR24C1050I1 (fr) Récepteurs d'antigènes chimériques basés sur des anticorps à domaine unique et leurs méthodes d'utilisation
FR25C1001I2 (fr) Compositions d'anticorps pour le traitement de tumeurs
IL286124A (en) Antibodies targeting b-cell maturation antigen and methods of use
IL261713B1 (en) Methods and compositions for transducing lymphocytes and regulated expansion thereof
EP3869985A4 (de) Zusammensetzung und verfahren zur behandlung der lungen
EP3589646A4 (de) Cd19-zusammensetzungen und verfahren für die immuntherapie
IL284853A (en) Compositions and methods for inhibition of lineage specific antigens
IL266918A (en) Anti-ctla-4 antibodies and methods of using them
EP3445407A4 (de) Zusammensetzungen und verfahren zur zellulären immuntherapie
EP3468506A4 (de) Vorrichtung für herzklappenreparatur und verfahren zur implantation davon
EP3759218A4 (de) Verfahren und zusammensetzungen für antikörperausweichende virusvektoren
EP3356390A4 (de) Verfahren und zusammensetzungen für antikörperausweichende virusvektoren
MA71409A (fr) Constructions d'anticorps pour dll3 et cd3
EP3526718A4 (de) Identitätsüberprüfung mittels virtueller realität
EP3423044A4 (de) Sting-aktivierender nanoimpfstoff zur immuntherapie
MA42925A (fr) Anticorps anti-tigit et méthodes d'utilisation
MA51552A (fr) Anticorps anti-ox40 et procédés d'utilisation
EP3672472A4 (de) Werkzeuge und verfahren für den vaginalzugang
MA52308A (fr) Procédés et intermédiaires pour la préparation d'antagonistes c5ar
EP3519572A4 (de) Verbindungen und verfahren zur verminderung der tau-expression
SG10202010155YA (en) Compositions and methods for making antibodies based on use of expression-enhancing loci
EP3500262A4 (de) Zusammensetzungen und verfahren für die krebsimmuntherapie
SG11202110121VA (en) Compositions and methods for retrieving tumor-related antibodies and antigens
EP3434291A4 (de) Zusammensetzung zur behandlung von bandscheiben
EP3488018A4 (de) Verfahren und zusammensetzungen zur proteinidentifikation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181026

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20191204

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 39/09 20060101ALI20191128BHEP

Ipc: A61K 39/02 20060101AFI20191128BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20220429

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20221005